Abubakar Hussein AHMED, Plaintiff-Appellant, v. ARIZONA DEPARTMENT OF TRANSPORTATION, ADOT agent of Stacey K Stanton; et al., Defendants-Appellees.
No. 15-17136
United States Court of Appeals, Ninth Circuit.
April 21, 2017
672 Fed. Appx. 672
Before: GOULD, CLIFTON, and HURWITZ, Circuit Judges.
Submitted April 11, 2017. Abubakar Hussein Ahmed, Pro Se.
Abubakar Hussein Ahmed appeals pro se from the district court’s order dismissing his action brought under
The district court abused its discretion in denying Ahmed’s IFP application in light of the $400 filing fee and Ahmed’s declaration showing a monthly income of only $425 and no assets. See id. (“An affidavit in support of an IFP application is sufficient where it alleges that the affiant cannot pay the court costs and still afford the necessities of life.”). Ahmed’s filings before this court, however, suggest Ahmed may no longer be indigent. We therefore vacate the district court’s dismissal and remand with instructions for the district court to permit Ahmed to either file another IFP application or to pay the filing fee.
We reject as without merit Ahmed’s contentions that he was denied due process in the district court.
Ahmed’s request for reimbursement of the filing fee on appeal, set forth in his opening brief, is denied.
VACATED and REMANDED.
UNITED STATES of America, Plaintiff-Appellee, v. Richard C. SPRINGS, Defendant-Appellant.
No. 16-30073
United States Court of Appeals, Ninth Circuit.
April 21, 2017
674 Fed. Appx. 674
Before: W. FLETCHER and GOULD, Circuit Judges, and BLOCK,* District Judge.
Argued and Submitted April 7, 2017 Seattle, Washington. Rudy J. Verschoor, Assistant U.S. Attorney, USSP—Office of the U.S. Attorney, Spokane, WA, for Plaintiff-Appellee. Richard C. Springs, Pro Se.
Defendant-Appellant Richard Springs is charged with violating
To obtain a forcible medication order under Sell, the government must prove all four Sell factors by clear and convincing evidence. United States v. Ruiz-Gaxiola, 623 F.3d 684, 692 (9th Cir. 2010). The first Sell factor—whether important governmental interests are at stake in prosecuting the defendant for the charged offense—is a legal question that we review de novo. See id. at 693. The remaining Sell factors—whether involuntary medication will significantly further the government’s interest, whether involuntary medication is necessary to further those interests, and whether the recommended course of treatment is in the patient’s best medical interest—we review for clear error. See id. We have jurisdiction under the collateral order exception to
1. The district court did not err in determining “that important government interests are at stake” in prosecuting Springs. Id. at 180. Springs concedes that his alleged crime—threatening to kill federal judges—is serious, but argues that special circumstances lessen that interest. The parties do not dispute that the applicable Sentencing Guidelines range is on the low end at 21-27 months, and Springs has already been in custody for nearly three years. Although Springs has been confined for a significant amount of time, and it is possible that he will be sentenced to time served, this fact “does not totally undermine[ ] the strength of the need for prosecution.” Id. Spring’s sentence, if he is convicted, is likely to include a period of supervised release, which “would help ensure that [Springs] does not return to making threats when released into the public.” United States v. Gillenwater, 749 F.3d 1094, 1102 (9th Cir. 2014). Further, if Springs is convicted, there may be less likelihood that others would make unlawful threats against federal judges. See United States v. Onuoha, 820 F.3d 1049, 1056-57 (9th Cir. 2016) (concluding that important governmental interests were at stake in part because of the defen
2. The district court did not clearly err in finding that “involuntary medication will significantly further” the government’s interest in prosecuting Springs. Sell, 539 U.S. at 181. The district court heard medical testimony that treating Springs with Abilify was substantially likely to render Springs competent and “substantially unlikely to have side effects that will interfere significantly with [his] ability to assist counsel.” Id. This testimony was supported by studies that described treating delusional disorder with antipsychotic medication, including Abilify or its generic equivalent. Springs did not provide expert testimony on his behalf or otherwise discredit the evidence offered by the government, which was thus uncontested. And Springs himself testified that he had previously taken Abilify and experienced some symptom abatement without serious side effects.
3. The district court did not clearly err in finding that “involuntary medication is necessary to further” the government’s interest. Id. The district court had previously ordered that medical staff attempt psychotherapy, and the government’s experts explained why talk therapy was ineffective in Springs’s case. The district court also ordered less intrusive means for administering Abilify by first providing Springs the opportunity to take oral doses.
4. The district court did not clearly err in finding that the “administration of drugs is medically appropriate.” Id. Several facts support this finding: Springs previously took Abilify and testified to experiencing improvement without serious side effects; the government’s expert testified that Abilify had the mildest side effects of all antipsychotic drugs available to psychiatrists in the United States; and experts testified that medication would likely provide significant medical benefits to Springs. Defense counsel also conceded that Abilify was an appropriate medication to treat delusional disorder. The district court properly considered Springs’s “long-term medical interests ... rather than the short-term institutional interests of the justice system” in concluding that the government met this fourth factor. Ruiz-Gaxiola, 623 F.3d at 703.
5. The district court was not required to make a separate finding of dangerousness. See Sell, 539 U.S. at 183. The government previously sought permission to forcibly medicate Springs pursuant to Washington v. Harper, which permits involuntary medication of a defendant if his mental illness renders him dangerous to himself or to others and if the treatment is in his best medical interest. 494 U.S. 210, 227 (1990). After an administrative panel determined that Springs could not be involuntarily medicated under Harper, the government then sought permission under Sell.
* * *
Sell orders to involuntarily medicate a defendant for the purpose of restoring competency to stand trial are disfavored in light of the liberty interests at stake and should occur “only in rare circumstances.” Ruiz-Gaxiola, 623 F.3d at 687; see Sell, 539 U.S. at 180. But based on the importance of the government’s interest in prosecuting this case, the evidentiary record presented, and the district court’s extensive and thoughtful fact-finding, we conclude that this is one of those rare circumstances. We affirm the district court’s Sell order.
AFFIRMED.